SCHEMBL4018676

SCHEMBL4018676

NC(=O)c1ccc(Oc2c(F)cc(CNC(O)C3CCCCC3)cc2F)cc1O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 4/20 0.41
PARP15 Q460N3 3/20 0.38
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
MITF O75030 2/20 0.33
THRB P10828 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
XBP1 P17861 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
EPHX1 P07099 4/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
EGLN2 Q96KS0 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019651 0.89 PARP10 (0.40) PARP10PARP15LMNAMEN1KMT2A
SCHEMBL4018141 0.86 PARP10 (0.44) PARP10PARP15TDP1ALDH1A1LMNA
SCHEMBL4020004 0.77 FYN (0.42) PARP10PARP15ALDH1A1LMNAKDM4E
SCHEMBL4016203 0.77 PARP10 (0.39) PARP10PARP15MAOAMAOB
SCHEMBL4018667 0.76 FPR2 (0.39) PARP10PARP15MAOAMAOBEGLN2
SCHEMBL4018367 0.76 ATM (0.44) ALDH1A1LMNAKDM4EPKMMEN1
SCHEMBL4014221 0.74 MEN1 (0.36) PARP10PARP15MITFMAPTNPSR1
SCHEMBL4018723 0.74 OPRM1 (0.41) PARP10PARP15
SCHEMBL4020001 0.68 PARP10 (0.33) PARP10PARP15ALDH1A1LMNAKDM4E
SCHEMBL4024269 0.67 LMNA (0.42) LMNAMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US claimed
EP-2064199-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF Pfizer Products Inc. (US) 2009-06-03 EP claimed
WO-2008032156-A1 DIARYL ETHER DERIVATIVES AND USES THEREOF PFIZER PRODUCTS INC. (US) 2008-03-20 WO claimed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof OPRD1, OPRK1, OPRL1 PARP10 2285/4885PARP15 3250/4885TDP1 3340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.